Different Effects of Implanting Sensory Nerve or Blood Vessel on the Vascularization, Neurotization, and Osteogenesis of Tissue-Engineered Bone In Vivo

To compare the different effects of implanting sensory nerve tracts or blood vessel on the osteogenesis, vascularization, and neurotization of the tissue-engineered bone in vivo, we constructed the tissue engineered bone and implanted the sensory nerve tracts (group SN), blood vessel (group VB), or nothing (group Blank) to the side channel of the bone graft to repair the femur defect in the rabbit. Better osteogenesis was observed in groups SN and VB than in group Blank, and no significant difference was found between groups SN and VB at 4, 8, and 12 weeks postoperatively. The neuropeptides expression and the number of new blood vessels in the bone tissues were increased at 8 weeks and then decreased at 12 weeks in all groups and were highest in group VB and lowest in group Blank at all three time points. We conclude that implanting either blood vessel or sensory nerve tract into the tissue-engineered bone can significantly enhance both the vascularization and neurotization simultaneously to get a better osteogenesis effect than TEB alone, and the method of implanting blood vessel has a little better effect of vascularization and neurotization but almost the same osteogenesis effect as implanting sensory nerve.

[1]  G. Pei,et al.  Different effects of implanting vascular bundles and sensory nerve tracts on the expression of neuropeptide receptors in tissue-engineered bone in vivo , 2010, Biomedical materials.

[2]  G. Pei,et al.  [Experimental study on construction of neurotization tissue engineered bone for repairing large bone defects in rabbit]. , 2010, Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery.

[3]  H. Herzog,et al.  NPY regulation of bone remodelling , 2009, Neuropeptides.

[4]  G. Pei,et al.  [A study of the different effect on the expression of calcitonin gene related peptide and neuropeptide Y in tissue engineered bone with vascular bundle graft in vivo and that with sensory nerve tract graft in vivo]. , 2008, Zhonghua wai ke za zhi [Chinese journal of surgery].

[5]  J. Grauer,et al.  Silicates and bone fusion. , 2008, Orthopedics.

[6]  J. Kanczler,et al.  Osteogenesis and angiogenesis: the potential for engineering bone. , 2008, European cells & materials.

[7]  V. Patel,et al.  Calcium phosphates as bone graft extenders. , 2007, Orthopedics.

[8]  A. Maclean,et al.  Available biological treatments for complex non-unions. , 2007, Injury.

[9]  Ulrich Kneser,et al.  Axial prevascularization of porous matrices using an arteriovenous loop promotes survival and differentiation of transplanted autologous osteoblasts. , 2007, Tissue engineering.

[10]  T. Miclau,et al.  Autologous iliac crest bone graft: should it still be the gold standard for treating nonunions? , 2007, Injury.

[11]  A Arkudas,et al.  Autonomously vascularized cellular constructs in tissue engineering: opening a new perspective for biomedical science , 2007, Journal of cellular and molecular medicine.

[12]  Andreas Hess,et al.  Engineering of vascularized transplantable bone tissues: induction of axial vascularization in an osteoconductive matrix using an arteriovenous loop. , 2006, Tissue engineering.

[13]  S. R. Haug,et al.  Modulation of Dental Inflammation by the Sympathetic Nervous System , 2006, Journal of dental research.

[14]  H. Ohgushi,et al.  Experimental Study of Vascularized Tissue-Engineered Bone Grafts , 2006, Plastic and reconstructive surgery.

[15]  U Kneser,et al.  Tissue engineering of bone: the reconstructive surgeon's point of view , 2006, Journal of cellular and molecular medicine.

[16]  T. Bivalacqua,et al.  Engineering Ex Vivo–Expanded Marrow Stromal Cells to Secrete Calcitonin Gene–Related Peptide Using Adenoviral Vector , 2004, Stem cells.

[17]  Y. Tabata,et al.  Prefabrication of vascularized bone graft using guided bone regeneration. , 2004, Tissue engineering.

[18]  G. Roodman.  Mechanisms of bone metastasis. , 2004, Discovery medicine.

[19]  I. Keith,et al.  Targeted blocking of gene expression for CGRP receptors elevates pulmonary artery pressure in hypoxic rats. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[20]  H. Struijker‐Boudier,et al.  Calcitonin gene–related peptide: Exploring its vasodilating mechanism of action in humans , 2003, Clinical pharmacology and therapeutics.

[21]  A. Rubinacci,et al.  Human osteoblast-like cell proliferation induced by calcitonin-related peptides involves PKC activity. , 2003, American Journal of Physiology. Endocrinology and Metabolism.

[22]  P. Delmas,et al.  Evidence for a dense and intimate innervation of the bone tissue, including glutamate-containing fibers. , 1999, Bone.

[23]  R. Baron,et al.  Ablation of the PTHrP gene or the PTH/PTHrP receptor gene leads to distinct abnormalities in bone development. , 1999, The Journal of clinical investigation.

[24]  I. Reid,et al.  Comparison of the Effects of Calcitonin Gene‐Related Peptide and Amylin on Osteoblasts , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  P. Marie,et al.  Calcitonin gene-related peptide (CGRP) increases intracellular free Ca2+ concentrations but not cyclic AMP formation in CGRP receptor-positive osteosarcoma cells (OHS-4). , 1999, Cytokine.

[26]  D. Mangham,et al.  Autologous Bone Grafting in Staged Scoliosis Surgery: The Patient as Bone Bank , 1998, Spine.

[27]  T. Maeda,et al.  Calcitonin gene‐related peptide, substance P, and tyrosine hydroxylase‐immunoreactive innervation of rat bone marrows: An immunohistochemical and ultrastructural investigation on possible efferent and afferent mechanisms , 1997, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[28]  A. Kreicbergs,et al.  The development of autonomic innervation in bone and joints of the rat. , 1996, Journal of the autonomic nervous system.

[29]  Y. Tanaka,et al.  Bone marrow capacity for bone cells and trabecular bone turnover in immobilized tibia after sciatic neurectomy in mice. , 1996, Bone.

[30]  T. McCarthy,et al.  The neuropeptide calcitonin gene-related peptide stimulates insulin-like growth factor I production by primary fetal rat osteoblasts. , 1996, Bone.

[31]  D. Webb,et al.  Interaction of Neuropeptide Y and the Sympathetic Nervous System in Vascular Control in Man John Clarke, MRCPI; , 1991, Circulation.

[32]  T. Fujita,et al.  Calcitonin gene-related peptide receptor in cultured vascular smooth muscle and endothelial cells. , 1988, Biochemical and biophysical research communications.

[33]  G. Mundy,et al.  Human synthetic calcitonin gene-related peptide inhibits bone resorption in vitro. , 1986, Endocrinology.

[34]  E. Hohmann,et al.  Innervation of periosteum and bone by sympathetic vasoactive intestinal peptide-containing nerve fibers. , 1986, Science.

[35]  C. Bünger,et al.  Vasoconstrictive action of neuropeptide Y in bone. The porcine tibia perfused in vivo. , 1994, Acta orthopaedica Scandinavica.

[36]  D. Simmons,et al.  The healing of grafts combining freeze-dried and demineralized allogeneic bone in rabbits. , 1994, Clinical orthopaedics and related research.

[37]  I. Kjaer.  Correlated appearance of ossification and nerve tissue in human fetal jaws. , 1990, Journal of craniofacial genetics and developmental biology.